| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.63 MB | Adobe PDF |
Authors
Abstract(s)
Introdução: A 11 de março de 2020, a Organização Mundial de Saúde declarou a
COVID-19 como uma pandemia, impactando significativamente toda a vida pública e
economia global. Desde a sua descoberta, em Wuhan, a rápida propagação do vírus levou
a uma crise de saúde pública sem precedentes e à adoção de medidas extremas para limitar
a propagação comunitária e hospitalar. Fruto de uma confluência de circunstâncias
extraordinárias, as doutrinas de tratamento para pacientes portadores de carcinoma da
cabeça e pescoço tiveram de ser reanalisadas, garantindo o bem-estar tanto dos pacientes,
como dos profissionais de saúde e da própria sociedade.
Materiais e Métodos: A presente revisão sistemática fundamentou-se nas guidelines
PRISMA. Assim, a pesquisa bibliográfica foi realizada nas plataformas LILACS®;
PubMed®; Web of Science®, Cochrane COVID-19 Study Register®, Scielo® e
Scopus®, tendo como objetivo a resposta à pergunta de investigação, considerando o
objetivo e os critérios definidos.
Resultados: Foram, inicialmente, selecionados 837 artigos que após remoção dos
duplicados resultaram em 471 artigos. Após leitura do título e abstract foram selecionados
para leitura integral 67, com o intuito de avaliar sua elegibilidade. Assim, foram incluídos
15 artigos. Os resultados são heterogéneos fruto da contemporaneidade da temática.
Conclusão: Os estudos incluídos permitem descortinar impactos distintos, sentidos em
diferentes instituições de vários países, não permitindo tirar conclusões generalizáveis.
Algumas das variáveis analisadas levantam preocupações, nomeadamente a limitação de
cirurgias oncológicas, das cirurgias de reconstrução, bem como o aumento do número de
pacientes admitidos com classificações TNM e estágio geral mais avançado. Os
resultados obtidos permitem constatar um esforço para que a pandemia não condicionasse
os cuidados prestados. Os verdadeiros efeitos serão evidenciados à medida que se retomar
a normalidade e novos estudos avaliarem mortalidade, morbidade e estágio geral dos
pacientes que procuram cuidados médicos.
Introduction: On March 11, 2020, the World Health Organization declared COVID-19 as pandemic, significantly impacting all public life and the global economy. Since its discovery in Wuhan, the rapid spread of the virus has led to an unprecedented public health crisis and the adoption of extreme measures to limit community and hospital spread. As a result of a confluence of extraordinary circumstances caused by this pandemic, the doctrines of treatment for patients with head and neck carcinoma had to be reanalyzed, guaranteeing the well-being of both patients and health professionals as also society itself. Materials and Methods: This systematic review was based on the PRISMA guidelines. Thus, the bibliographic research was carried out on the following plataforms: LILACS®; PubMed®; Web of Science®, Cochrane COVID-19 Study Register®, Scielo® and Scopus®, aiming to answer the research question, considering the objective and defined criteria. Results: Initially, 837 articles were selected, which after removal of duplicates resulted in 471 articles. After reading the title and abstract, 67 articles were selected for full reading, in order to assess their eligibility. Thus, 15 articles were included. The results are heterogeneous as a result of the contemporaneity of the thematic. Conclusion: The studies included allow to unveil distinct impacts, felt in different institutions of several countries, not allowing generalizable conclusions to be drawn. Some of the variables analyzed raise concerns, namely the limitation of oncologic surgeries, reconstruction surgeries, as well as the increase in the number of patients admitted with higher TNM classifications and more advanced general stage. The results obtained show an effort so that the pandemic did not affect the care provided. The true effects will be evident as normality returns and new studies assess mortality, morbidity and general stage of patients seeking medical care.
Introduction: On March 11, 2020, the World Health Organization declared COVID-19 as pandemic, significantly impacting all public life and the global economy. Since its discovery in Wuhan, the rapid spread of the virus has led to an unprecedented public health crisis and the adoption of extreme measures to limit community and hospital spread. As a result of a confluence of extraordinary circumstances caused by this pandemic, the doctrines of treatment for patients with head and neck carcinoma had to be reanalyzed, guaranteeing the well-being of both patients and health professionals as also society itself. Materials and Methods: This systematic review was based on the PRISMA guidelines. Thus, the bibliographic research was carried out on the following plataforms: LILACS®; PubMed®; Web of Science®, Cochrane COVID-19 Study Register®, Scielo® and Scopus®, aiming to answer the research question, considering the objective and defined criteria. Results: Initially, 837 articles were selected, which after removal of duplicates resulted in 471 articles. After reading the title and abstract, 67 articles were selected for full reading, in order to assess their eligibility. Thus, 15 articles were included. The results are heterogeneous as a result of the contemporaneity of the thematic. Conclusion: The studies included allow to unveil distinct impacts, felt in different institutions of several countries, not allowing generalizable conclusions to be drawn. Some of the variables analyzed raise concerns, namely the limitation of oncologic surgeries, reconstruction surgeries, as well as the increase in the number of patients admitted with higher TNM classifications and more advanced general stage. The results obtained show an effort so that the pandemic did not affect the care provided. The true effects will be evident as normality returns and new studies assess mortality, morbidity and general stage of patients seeking medical care.
Description
Keywords
Cancro da cabeça e pescoço COVID-19 Tratamento Impacto Consequências Head and neck cancer Treatment Impact Consequences